Repare Therapeutics
$0.00 (0.00%) As of 12:58 PM UTC pre-market
Why Robinhood?
You can buy or sell RPTX and other stocks, options, and ETFs commission-free!
About RPTX
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
CEO
Lloyd M. Segal
Employees
102
Headquarters
Saint-Laurent, Québec
Founded
2016
RPTX Key Statistics
Market Cap
1.24B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
160.86K
High Today
$33.92
Low Today
$32.85
Open Price
$33.79
Volume
90.41K
52 Week High
$46.44
52 Week Low
$21.45
Analyst Ratings
86%
of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
RPTX Earnings
-$2.45
-$1.63
-$0.82
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours